MeSH term
Frequency | Condition_Probility | Adult | 9 | 0.0 |
Alleles | 3 | 0.0 |
Apolipoprotein A-II/*genetics | 5 | 50.0 |
Female | 12 | 0.0 |
Humans | 27 | 0.0 |
Microsatellite Repeats/*genetics | 2 | 0.0 |
Middle Aged | 6 | 0.0 |
Chromosome Disorders | 3 | 0.0 |
Comparative Study | 4 | 0.0 |
Genetic Markers | 6 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Aged | 3 | 0.0 |
European Continental Ancestry Group/genetics | 2 | 0.0 |
Lod Score | 8 | 0.0 |
Pedigree | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 19 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Risk Factors | 2 | 0.0 |
Lipoproteins/*blood | 2 | 0.0 |
Male | 14 | 0.0 |
Blotting, Southern | 2 | 0.0 |
*Chromosomes, Human, Pair 1 | 10 | 2.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Chromosome Mapping | 9 | 0.0 |
Chromosomes, Human, Pair 1/*genetics | 2 | 0.0 |
Linkage (Genetics) | 5 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Triglycerides/blood | 2 | 0.0 |
Chromosome Aberrations/*genetics | 2 | 1.0 |
Karyotyping | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Apolipoproteins/blood | 2 | 0.0 |
Child | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
DNA | 2 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Lipids/*blood | 2 | 0.0 |
Charcot-Marie-Tooth Disease/*genetics | 2 | 1.0 |
*Linkage (Genetics) | 3 | 0.0 |
Muscular Atrophy, Spinal/*genetics | 2 | 3.0 |
DNA/genetics | 2 | 0.0 |
Animals | 5 | 0.0 |
Mice | 4 | 0.0 |
Apolipoprotein A-II | 3 | 6.0 |
Apolipoproteins A/*genetics | 3 | 6.0 |
Cloning, Molecular | 2 | 0.0 |
*Genes, Structural | 2 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Finland | 2 | 0.0 |
